1. Home
  2. GLMD vs GITS Comparison

GLMD vs GITS Comparison

Compare GLMD & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • GITS
  • Stock Information
  • Founded
  • GLMD 2000
  • GITS 2018
  • Country
  • GLMD Israel
  • GITS South Korea
  • Employees
  • GLMD N/A
  • GITS N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • GITS
  • Sector
  • GLMD Health Care
  • GITS
  • Exchange
  • GLMD Nasdaq
  • GITS Nasdaq
  • Market Cap
  • GLMD 3.0M
  • GITS 3.4M
  • IPO Year
  • GLMD 2014
  • GITS N/A
  • Fundamental
  • Price
  • GLMD $1.51
  • GITS $2.02
  • Analyst Decision
  • GLMD Hold
  • GITS
  • Analyst Count
  • GLMD 1
  • GITS 0
  • Target Price
  • GLMD N/A
  • GITS N/A
  • AVG Volume (30 Days)
  • GLMD 255.6K
  • GITS 2.9M
  • Earning Date
  • GLMD 06-17-2025
  • GITS 07-15-2025
  • Dividend Yield
  • GLMD N/A
  • GITS N/A
  • EPS Growth
  • GLMD N/A
  • GITS N/A
  • EPS
  • GLMD N/A
  • GITS N/A
  • Revenue
  • GLMD N/A
  • GITS N/A
  • Revenue This Year
  • GLMD N/A
  • GITS N/A
  • Revenue Next Year
  • GLMD N/A
  • GITS N/A
  • P/E Ratio
  • GLMD N/A
  • GITS N/A
  • Revenue Growth
  • GLMD N/A
  • GITS N/A
  • 52 Week Low
  • GLMD $1.15
  • GITS $0.87
  • 52 Week High
  • GLMD $23.80
  • GITS $9.78
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 56.28
  • GITS N/A
  • Support Level
  • GLMD $1.36
  • GITS N/A
  • Resistance Level
  • GLMD $1.60
  • GITS N/A
  • Average True Range (ATR)
  • GLMD 0.09
  • GITS 0.00
  • MACD
  • GLMD 0.03
  • GITS 0.00
  • Stochastic Oscillator
  • GLMD 79.07
  • GITS 0.00

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

About GITS Global Interactive Technologies Inc. Common Stock

Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

Share on Social Networks: